ADC Therapeutics (ADCT) EBIT Margin (2021 - 2026)
ADC Therapeutics (ADCT) recorded EBIT Margin of -132.03% in Q2 2026, up 102.30 percentage points from -234.34% a year earlier but down 10.96 percentage points from the prior quarter.
Powered by 
Analysis
ADC Therapeutics (ADCT) EBIT Margin (2021 - 2026) Analysis & Trends
On a TTM basis, ADC Therapeutics' EBIT Margin came in at -166.89% as of Jun 30, 2026, up 9.60 percentage points year-over-year.
- Quarterly EBIT Margin has ranged from -439.58% in Q3 2021 to -4.08% in Q3 2022 over the past five years.
- On a year-over-year basis, EBIT Margin rose in five of the last six quarters, with an average year-over-year change of +26.80 percentage points.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 1473.09 percentage points in Q2 2022, against a drop of 245.34 percentage points in Q3 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.68 Bn | 1,105.26 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.43 Bn | 535.95 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 501.53 Bn | 474.64 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 368.15 Bn | 322.53 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 297.54 Bn | 261.53 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 260.75 Bn | 234.43 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 236.53 Bn | 191.93 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 191.10 Bn | 165.30 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 169.66 Bn | 116.31 Bn | 10.94 Bn | 28.37% |
| 10 | ADC Therapeutics | 233.30 Mn | -712.89 Mn | 16.90 Mn | -132.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -132.03% |
| Mar 31, 2026 | -121.07% |
| Sep 30, 2025 | -188.52% |
| Jun 30, 2025 | -234.34% |
| Mar 31, 2025 | -123.58% |
| Sep 30, 2024 | -192.61% |
| Jun 30, 2024 | -166.81% |
| Mar 31, 2024 | -186.19% |
| Sep 30, 2023 | -249.42% |
| Jun 30, 2023 | -205.62% |
| Mar 31, 2023 | -271.55% |
| Sep 30, 2022 | -4.08% |
| Jun 30, 2022 | -401.43% |
| Mar 31, 2022 | -86.81% |
| Sep 30, 2021 | -439.58% |
| Jun 30, 2021 | -1,874.52% |
API Access
ADC Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ADCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ADCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ADCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();